Forrester Jade, Davidson Callum G, Blair May, Donlon Lynn, McLoughlin Daragh M, Obiora Chukwuebuka R, Stockdale Heather, Thomas Ben, Nutman Martina, Brockbank Sarah, Rattray Zahra, Perrie Yvonne
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.
Centre for Process Innovation (CPI), Coxon Building, John Walker Rd., Sedgefield, Stockton-on-Tees TS21 3FE, UK.
Pharmaceutics. 2025 Apr 25;17(5):566. doi: 10.3390/pharmaceutics17050566.
: Microfluidic mixing has become the gold standard procedure for manufacturing nucleic acid lipid-based delivery systems, offering precise control over critical process parameters. The choice and design of microfluidic mixers are often seen as a key driving force affecting the critical quality attributes of the resulting lipid nanoparticles (LNPs). : This study aimed to evaluate LNPs manufactured using two low-cost microfluidic mixers alongside manual mixing (pipette mixing (PM)), followed by characterization studies using orthogonal analytics as well as expression studies to establish whether low-cost microfluidic manufacturing methods are suitable for bench-scale and high-throughput research. : The results show that all manufacturing methods can produce LNPs with sizes ranging between 95 and 215 nm with high encapsulation (70-100%), and enhanced analytics showed variations between the LNPs produced using the different mixers. Despite these differences, pipette mixing production of LNPs demonstrated its application as a high-throughput screening tool for LNPs, effectively distinguishing between different formulations and predicting consistent expression patterns both in vitro and in vivo. : Overall, these results validate the use of low-cost microfluidic mixers without compromising the efficiency and integrity of the resulting LNPs. This study supports the increased accessibility of small-scale LNP manufacturing and high-throughput screening.
微流控混合已成为制造基于核酸脂质的递送系统的金标准程序,可对关键工艺参数进行精确控制。微流控混合器的选择和设计通常被视为影响所得脂质纳米颗粒(LNP)关键质量属性的关键驱动力。
本研究旨在评估使用两种低成本微流控混合器以及手动混合(移液管混合(PM))制造的LNP,随后进行使用正交分析的表征研究以及表达研究,以确定低成本微流控制造方法是否适用于实验室规模和高通量研究。
结果表明,所有制造方法都可以生产尺寸在95至215纳米之间、具有高封装率(70 - 100%)的LNP,增强分析显示使用不同混合器生产的LNP之间存在差异。尽管存在这些差异,但通过移液管混合生产LNP证明了其作为LNP高通量筛选工具的应用,能够有效区分不同配方并预测体外和体内的一致表达模式。
总体而言,这些结果验证了低成本微流控混合器的使用,同时不影响所得LNP的效率和完整性。本研究支持了小规模LNP制造和高通量筛选的更高可及性。